44 results on '"Walder, Ken"'
Search Results
2. The potential of baicalin to enhance neuroprotection and mitochondrial function in a human neuronal cell model
3. Network-based drug repurposing for schizophrenia
4. Metergoline Shares Properties with Atypical Antipsychotic Drugs Identified by Gene Expression Signature Screen
5. CaMKK2 as an emerging treatment target for bipolar disorder
6. Class IIa HDACs inhibit cell death pathways and protect muscle integrity in response to lipotoxicity
7. A plasma protein signature associated with cognitive function in men without severe cognitive impairment
8. Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine
9. Use of gene regulatory network analysis to repurpose drugs to treat bipolar disorder
10. Diet and depression: future needs to unlock the potential
11. Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis
12. The role of metformin as a treatment for neuropsychiatric illness
13. Brain derived neurotrophic factor in perioperative neurocognitive disorders: Current evidence and future directions
14. Common effects of bipolar disorder medications on expression quantitative trait loci genes
15. Genetic polymorphism in BIN1 rather than APOE is associated with poor recognition memory among men without dementia
16. Intertwined associations between oxidative and nitrosative stress and endocannabinoid system pathways: Relevance for neuropsychiatric disorders
17. Amyloid beta 42 alters cardiac metabolism and impairs cardiac function in male mice with obesity
18. Effects of antipsychotic drugs on energy metabolism
19. Association of mood disorder and bone health with cognitive function among healthy ageing men
20. Impact of Mood Disorder History and Bone Health on Cognitive Function Among Men Without Dementia
21. Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management
22. Leveraging genetic diversity to identify small molecules that reverse mouse skeletal muscle insulin resistance
23. Author Response: Leveraging genetic diversity to identify small molecules that reverse mouse skeletal muscle insulin resistance
24. Leveraging genetic diversity to identify small molecules that reverse mouse skeletal muscle insulin resistance
25. Use of a gene expression signature to identify trimetazidine for repurposing to treat bipolar depression
26. Minocycline as Treatment for Psychiatric and Neurological Conditions: A Systematic Review and Meta-Analysis
27. Adjunctive minocycline for major depressive disorder: A sub-study exploring peripheral immune-inflammatory markers and associated treatment response
28. Identification of reversible and druggable pathways to improve beta-cell function and survival in Type 2 diabetes
29. Class IIa HDACs reprogram mitochondrial metabolism to inhibit apoptosis and ferroptosis in response to lipotoxicity
30. Amyloid beta 42 alters cardiac metabolism and impairs cardiac function in obesity
31. Metformin is Protective Against the Development of Mood Disorders
32. Repurposing Drugs via Network Analysis: Opportunities for Psychiatric Disorders
33. Integrative Analyses of Transcriptomes to Explore Common Molecular Effects of Antipsychotic Drugs
34. Effects of Psychotropic Drugs on Ribosomal Genes and Protein Synthesis
35. Genetic polymorphism in BIN1 rather than APOE is associated with poor recognition memory among men without dementia
36. Co-Expression Networks Unveiled Long Non-Coding RNAs as Molecular Targets of Drugs Used to Treat Bipolar Disorder
37. Depression and bone loss as risk factors for cognitive decline: A systematic review and meta-analysis
38. Exploring interleukin-6, lipopolysaccharide-binding protein and brain-derived neurotrophic factor following 12 weeks of adjunctive minocycline treatment for depression
39. Metformin is Protective Against the Development of Mood Disorders.
40. Diet and depression: future needs to unlock the potential
41. Exploring interleukin-6, lipopolysaccharide-binding protein and brain-derived neurotrophic factor following 12 weeks of adjunctive minocycline treatment for depression.
42. A multianalyte plasma protein signature associated with cognitive function in a healthy ageing population.
43. Adjunctive minocycline for major depressive disorder: A sub-study exploring peripheral immune-inflammatory markers and associated treatment response
44. Associations between methamphetamine use disorder and SLC18A1 , SLC18A2 , BDNF , and FAAH gene sequence variants and expression levels.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.